Depressive Symptoms

Disease

Related News

New Research Uncovers Long COVID's Lasting Impact on Brain, Lungs, and Mental Health

May 31, 2026

Two new studies reveal long COVID's lasting biological and mental health effects. A mouse study found coronavirus triggers prolonged lung and brain damage unlike influenza, while a population study linked long COVID to significantly higher depression and anxiety risks up to three years post-infection.

Pharmaceutical Stocks to Watch Include Eli Lilly, AbbVie, Vertex, Gilead and Pfizer

Apr 23, 2026

Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.

Brain Imaging and Precision Medicine Advance Treatment-Resistant Depression Therapies

Mar 14, 2026

New research reveals how ketamine rewires brain receptors to rapidly relieve severe depression, while separate trials demonstrate success with personalized brain stimulation and targeted drug therapy for treatment-resistant cases.